Velarion Records
Free. Unsubscribe any time.

Xenon Pharmaceuticals Inc. (XENE)

Xenon Pharmaceuticals Inc. filed 14 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 5 reporting owners, covering 30 transactions and 451,589 shares. 14 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. No results print is on file in this window, so no interval is measured.

What stands out

Trades in Xenon Pharmaceuticals Inc. 30

Adoption dates in Xenon Pharmaceuticals Inc. 5

Results prints in Xenon Pharmaceuticals Inc. 0

Trades before a print in Xenon Pharmaceuticals Inc. 0

Interval to Xenon Pharmaceuticals Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Xenon Pharmaceuticals Inc. states

Filing text: “10b5-1 trading plan adopted by the reporting person on September 27, 2024”

Sources: SEC EDGAR full-text search and the SEC submissions API.